Logo image of BRBR

BELLRING BRANDS INC (BRBR) Stock Fundamental Analysis

NYSE:BRBR - New York Stock Exchange, Inc. - US07831C1036 - Common Stock - Currency: USD

75.35  +2.39 (+3.28%)

After market: 75.35 0 (0%)

Fundamental Rating

5

Taking everything into account, BRBR scores 5 out of 10 in our fundamental rating. BRBR was compared to 35 industry peers in the Personal Care Products industry. While BRBR belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. BRBR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BRBR was profitable.
BRBR had a positive operating cash flow in the past year.
In the past 5 years BRBR has always been profitable.
In the past 5 years BRBR always reported a positive cash flow from operatings.
BRBR Yearly Net Income VS EBIT VS OCF VS FCFBRBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

BRBR has a Return On Assets of 31.57%. This is amongst the best in the industry. BRBR outperforms 100.00% of its industry peers.
BRBR has a Return On Invested Capital of 46.63%. This is amongst the best in the industry. BRBR outperforms 97.14% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRBR is significantly above the industry average of 15.96%.
The last Return On Invested Capital (46.63%) for BRBR is above the 3 year average (38.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 31.57%
ROE N/A
ROIC 46.63%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
BRBR Yearly ROA, ROE, ROICBRBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

With an excellent Profit Margin value of 13.32%, BRBR belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
In the last couple of years the Profit Margin of BRBR has declined.
The Operating Margin of BRBR (20.49%) is better than 94.29% of its industry peers.
BRBR's Operating Margin has been stable in the last couple of years.
BRBR's Gross Margin of 36.16% is on the low side compared to the rest of the industry. BRBR is outperformed by 77.14% of its industry peers.
BRBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.49%
PM (TTM) 13.32%
GM 36.16%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
BRBR Yearly Profit, Operating, Gross MarginsBRBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

BRBR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for BRBR has been reduced compared to 1 year ago.
The number of shares outstanding for BRBR has been increased compared to 5 years ago.
Compared to 1 year ago, BRBR has an improved debt to assets ratio.
BRBR Yearly Shares OutstandingBRBR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BRBR Yearly Total Debt VS Total AssetsBRBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 10.42 indicates that BRBR is not in any danger for bankruptcy at the moment.
BRBR has a Altman-Z score of 10.42. This is amongst the best in the industry. BRBR outperforms 91.43% of its industry peers.
BRBR has a debt to FCF ratio of 6.64. This is a slightly negative value and a sign of low solvency as BRBR would need 6.64 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.64, BRBR is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.64
Altman-Z 10.42
ROIC/WACC5.33
WACC8.75%
BRBR Yearly LT Debt VS Equity VS FCFBRBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

2.3 Liquidity

A Current Ratio of 3.35 indicates that BRBR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.35, BRBR belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
BRBR has a Quick Ratio of 1.55. This is a normal value and indicates that BRBR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.55, BRBR is doing good in the industry, outperforming 68.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.35
Quick Ratio 1.55
BRBR Yearly Current Assets VS Current LiabilitesBRBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.48% over the past year.
The earnings per share for BRBR have been decreasing by -12.29% on average. This is quite bad
The Revenue has grown by 21.00% in the past year. This is a very strong growth!
Measured over the past years, BRBR shows a quite strong growth in Revenue. The Revenue has been growing by 18.50% on average per year.
EPS 1Y (TTM)46.48%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%34.88%
Revenue 1Y (TTM)21%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%23.82%

3.2 Future

Based on estimates for the next years, BRBR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.28% on average per year.
The Revenue is expected to grow by 9.94% on average over the next years. This is quite good.
EPS Next Y18.74%
EPS Next 2Y16.49%
EPS Next 3Y16.79%
EPS Next 5Y14.28%
Revenue Next Year16.59%
Revenue Next 2Y13.77%
Revenue Next 3Y12.89%
Revenue Next 5Y9.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRBR Yearly Revenue VS EstimatesBRBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
BRBR Yearly EPS VS EstimatesBRBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 36.23, which means the current valuation is very expensive for BRBR.
BRBR's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.33, BRBR is valued a bit more expensive.
The Price/Forward Earnings ratio is 28.77, which means the current valuation is very expensive for BRBR.
The rest of the industry has a similar Price/Forward Earnings ratio as BRBR.
BRBR is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.37, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 36.23
Fwd PE 28.77
BRBR Price Earnings VS Forward Price EarningsBRBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BRBR's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRBR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 77.02
EV/EBITDA 23.3
BRBR Per share dataBRBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BRBR may justify a higher PE ratio.
BRBR's earnings are expected to grow with 16.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.93
PEG (5Y)N/A
EPS Next 2Y16.49%
EPS Next 3Y16.79%

0

5. Dividend

5.1 Amount

No dividends for BRBR!.
Industry RankSector Rank
Dividend Yield N/A

BELLRING BRANDS INC

NYSE:BRBR (4/22/2025, 8:04:01 PM)

After market: 75.35 0 (0%)

75.35

+2.39 (+3.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners98.12%
Inst Owner Change0.65%
Ins Owners1.49%
Ins Owner Change8.63%
Market Cap9.67B
Analysts82.73
Price Target87.57 (16.22%)
Short Float %2.19%
Short Ratio2.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.7%
Min EPS beat(2)0.44%
Max EPS beat(2)18.96%
EPS beat(4)4
Avg EPS beat(4)17.57%
Min EPS beat(4)0.44%
Max EPS beat(4)31.81%
EPS beat(8)8
Avg EPS beat(8)12.46%
EPS beat(12)12
Avg EPS beat(12)14.03%
EPS beat(16)15
Avg EPS beat(16)14.85%
Revenue beat(2)1
Avg Revenue beat(2)0.56%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)1.64%
Revenue beat(4)2
Avg Revenue beat(4)1.15%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)3.78%
Revenue beat(8)5
Avg Revenue beat(8)1.27%
Revenue beat(12)7
Avg Revenue beat(12)0.13%
Revenue beat(16)9
Avg Revenue beat(16)0.85%
PT rev (1m)-0.17%
PT rev (3m)4.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.94%
EPS NY rev (1m)0.17%
EPS NY rev (3m)3.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE 36.23
Fwd PE 28.77
P/S 4.61
P/FCF 77.02
P/OCF 75.28
P/B N/A
P/tB N/A
EV/EBITDA 23.3
EPS(TTM)2.08
EY2.76%
EPS(NY)2.62
Fwd EY3.48%
FCF(TTM)0.98
FCFY1.3%
OCF(TTM)1
OCFY1.33%
SpS16.36
BVpS-1.14
TBVpS-2.73
PEG (NY)1.93
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 31.57%
ROE N/A
ROCE 62.2%
ROIC 46.63%
ROICexc 50.23%
ROICexgc 73.56%
OM 20.49%
PM (TTM) 13.32%
GM 36.16%
FCFM 5.98%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
ROICexc(3y)42.57%
ROICexc(5y)39.59%
ROICexgc(3y)77.99%
ROICexgc(5y)768.49%
ROCE(3y)51.56%
ROCE(5y)45.04%
ROICexcg growth 3Y-71.38%
ROICexcg growth 5Y-2%
ROICexc growth 3Y6.3%
ROICexc growth 5Y16.08%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
F-Score7
Asset Turnover2.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.64
Debt/EBITDA 1.86
Cap/Depr 15.68%
Cap/Sales 0.14%
Interest Coverage 250
Cash Conversion 28.63%
Profit Quality 44.9%
Current Ratio 3.35
Quick Ratio 1.55
Altman-Z 10.42
F-Score7
WACC8.75%
ROIC/WACC5.33
Cap/Depr(3y)6.58%
Cap/Depr(5y)6.2%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)77.59%
Profit Quality(5y)290.17%
High Growth Momentum
Growth
EPS 1Y (TTM)46.48%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%34.88%
EPS Next Y18.74%
EPS Next 2Y16.49%
EPS Next 3Y16.79%
EPS Next 5Y14.28%
Revenue 1Y (TTM)21%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%23.82%
Revenue Next Year16.59%
Revenue Next 2Y13.77%
Revenue Next 3Y12.89%
Revenue Next 5Y9.94%
EBIT growth 1Y50.61%
EBIT growth 3Y32.15%
EBIT growth 5Y18.99%
EBIT Next Year25.08%
EBIT Next 3Y16.14%
EBIT Next 5Y12.72%
FCF growth 1Y93.37%
FCF growth 3Y-4.13%
FCF growth 5Y15.77%
OCF growth 1Y93.37%
OCF growth 3Y-4.07%
OCF growth 5Y15.22%